Company profile
Seaport Therapeutics, Inc.
Pipeline5 assets
- GlyphAlloSPT-300 / Allopregnanolone prodrug
- GlyphAgoSPT-320 / Agomelatine prodrug
- Glyph2BLSDSPT-348 / Non-hallucinogenic neuroplastogen prodrug
- GlyphCeleCelecoxib prodrug
Latest news0 items
All newsNo recent headlines yet.
New company coverage will appear here as soon as it is picked up.